BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Biocept, Inc. Announces CEO and Director Appointments

  October 6, 2008

   · 

  2 min read
• Business

  Galenea and Otsuka Pharmaceutical Co., Ltd. Extend & Expand Schizophrenia Research Collaboration Worth $75 Million

  October 6, 2008

   · 

  4 min read
• Drug Development

  CombinatoRx, Incorporated Says Drug Fails Trial, Shares Slump

  October 6, 2008

   · 

  1 min read
• Pharm Country

  Directors Take Greater Ownership in VirtualScopics, LLC

  October 6, 2008

   · 

  2 min read
• Business

  Oncalis AG Licenses PI3K Inhibitors From ChemDiv, Inc.

  October 6, 2008

   · 

  2 min read
• UCB Group CIMZIA(R) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn’s Patients

  October 6, 2008

   · 

  11 min read
• Drug Development

  Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain Results from Phase 3b Studies with Durezol Dosed Prior to Surgery

  October 6, 2008

   · 

  7 min read
• Policy

  OVATION Pharmaceuticals, Inc. Release: ATryn(R) (antithrombin alfa) BLA Filing Accepted by FDA

  October 6, 2008

   · 

  1 min read
• Drug Development

  Unigene Laboratories, Inc. Initiates Phase I Clinical Study for Oral PTH

  October 6, 2008

   · 

  1 min read
• Business

  GeneThera, Inc. Offered World Wide Rights to E.coli Vaccine From the University of New Mexico

  October 6, 2008

   · 

  1 min read